Search Within

Hematology-Oncology Fellows

Formats
  1. Meeting Abstract (636)
  2. Journal Article (509)
  3. Review (142)
  4. Editorial (64)
  5. Research Letter (50)
  6. Correspondence (15)
  7. Guidelines (6)
  8. Book Section (3)
  9. Conference Paper (2)
  10. Miscellaneous (2)
Groups
  1. Department of Medicine (1165)
  2. Graduate Medical Education (1122)
  3. GME, Medicine (1098)
  4. Hematologic Malignancies, Division of (752)
  5. Weinberg Fellows (660)
  6. Solid Tumor Oncology Division (617)

More Groups

People
  1. Jan Bewersdorf (102)
  2. Maria Palomba (94)
  3. Zachary Epstein-Peterson (94)
  4. Gunjan Shah (93)
  5. Gilles Salles (89)
  6. Michael Scordo (87)

More People

Years
  1. 2025 (165)
  2. 2024 (357)
  3. 2023 (296)
  4. 2022 (222)
  5. 2021 (159)
  6. 2020 (114)

More Years

Publications
  1. Blood (288)
  2. Journal of Clinical Oncology (219)
  3. Clinical Cancer Research (38)
  4. Annals of Oncology (35)
  5. Cancer Research (35)
  6. Journal of Thoracic Oncology (31)

More Publications

Publishers
  1. American Society of Hematology (323)
  2. American Society of Clinical Oncology (251)
  3. Elsevier Inc. (143)
  4. Nature Publishing Group (107)
  5. American Association for Cancer Research (104)
  6. Oxford University Press (61)

More Publishers

Results (1429)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pirtobrutinib monotherapy in patients with relapsed/refractory B-cell malignancies intolerant to prior covalent BTK inhibitor
    Meeting Abstract

    Munir, T.; Shah, N. N.; Wang, M.; Brown, J. R.; Patel, K.; Woyach, J.; Wierda, W. G.; Ujjani, C. S.; Eyre, T. A.; Zinzani, P. L.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Genetic basis of relapse after GPRCSD-targeted CAR T cells
    Research Letter

    Mi, X.; Penson, A.; Abdel-Wahab, O.; Mailankody, S.
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save
  • Frequency and outcomes of leptomeningeal metastases in patients with fusion-positive lung cancers
    Meeting Abstract

    Chen, M.; Sui, J.; Wilcox, J.; Yang, S. R.; Imber, B.; Offin, M.; Yu, H.; Kris, M. G.; Drilon, A. E.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Brain metastases in patients with fusion-positive lung cancers
    Meeting Abstract

    Sui, J. S.; Chen, M. F.; Wilcox, J.; Yang, S. R.; Li, B. T.; Riely, G. J.; Offin, M.; Yu, H. A.; Kris, M. G.; Drilon, A. E.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Beware: Tyrosine kinase inhibitors for lung cancers that inhibit MATE-1 can lead to "False" decreases in renal function
    Meeting Abstract

    Chen, M.; Harada, G.; Liu, D.; Dematteo, R.; Falcon, C.; Wilhelm, C.; Kris, M. G.; Drilon, A. E.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Understanding genomic and social determinants of cancer immunotherapy outcome across ancestry
    Meeting Abstract

    Carrot-Zhang, J.; Fong, C.; Waters, M.; Pichotta, K.; Jee, J.; Jutagir, D.; Ma, D.; Perea-Chamblee, T.; Kim, S.; Arora, K.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Factors associated with disease progression after discontinuation of immunotherapy for immune-related toxicity in non-small cell lung cancer
    Meeting Abstract

    Pecci, F.; Thummalapalli, R.; Alden, S.; Ricciuti, B.; Alessi, J. V.; Elkrief, A.; Rizvi, H.; Wang, X.; Egger, J. V.; Vaz, V. R.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Consolidation EGFR-tyrosine kinase inhibitor (TKI)vs. durvalumab vs. observation in unresectable EGFR-mutant stage III NSCLC
    Meeting Abstract

    Nassar, A. H.; Adib, E.; Kaldas, D.; Feng, J.; AbuAli, T.; Aredo, J.; Fitzgerald, B.; Bar, J.; Thummalapalli, R.; Parikh, K.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Identifying early and late hallmarks of plasticity in neuroendocrine transformation of lung cancer at single-cell level
    Meeting Abstract

    Chan, J. M.; Quintanal-Villalonga, A.; Sabet, A.; Manoj, P.; Masilionis, I.; Falcon, C.; Sohail, N.; Chun, J.; Nawy, T.; Mazutis, L.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Real-world landscape analysis of activating ERBB2/ERBB3 alterations in 107,561 tissue and plasma samples from patients with NSCLC
    Meeting Abstract

    Liu, D.; Jee, J.; Keller, R. B.; Schrock, A. B.; Drilon, A.; Oxnard, G. R.; Li, B. T.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save